Submitting risk management plans draft guidance document: Opioid products
Opioid products need to include specific content within their RMP to address: the risk and uncertainties of opioid-related harms in Canada and other risks and uncertainties posed by the product, where warranted.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2024-04-04
Data overview
- Formats
- HTML
- File languages
- English, French